Device / Technology News

RSS

Revised version of UPLIFT proves successful in preventing epilepsy-related depression

Emory researchers announced results of a new study that has proven successful in the prevention of depression in people diagnosed with epilepsy.

5 Dec 2012

Telestroke appears to be cost-effective for rural hospitals

Researchers have found that using telemedicine to deliver stroke care, also known as telestroke, appears to be cost-effective for rural hospitals that do not have an around-the-clock neurologist, or stroke expert, on staff.

5 Dec 2012

UBM Canon’s MedTech Innovate Seminars to be held from Feb. 12-14, 2013

Today UBM Canon announces the expansion of its educational events aimed at the medical technology sector, with new 'Innovation' seminars being held this February, 2013. The seminars, named MedTech Innovate Seminars, will run concurrently with the MD&M West Conference and Exhibition, one of the largest medical design and manufacturing events in the world.

5 Dec 2012

Simple breath analysis could be used for colorectal cancer screening

A new study published in BJS has demonstrated for the first time that a simple breath analysis could be used for colorectal cancer screening. The study is part of the "Improving Outcomes in Gastrointestinal Cancer" supplement.

5 Dec 2012

USPTO approves patent for Axiogenesis’ in vitro drug discovery assay to treat HCM

The USPTO approved a patent for Axiogenesis AG for the invention of its in vitro assay to screen pharmaceutical drug candidates for effectiveness and safety in treating Hypertrophic Cardiomyopathy (HCM).

5 Dec 2012

Bioinformaticians use molecular simulations to explain specific step in HIV virion maturation

Bioinformaticians at IMIM (Hospital del Mar Medical Research Institute) and UPF (Pompeu Fabra University) have used molecular simulation techniques to explain a specific step in the maturation of the HIV virions, i.e., how newly formed inert virus particles become infectious, which is essential in understanding how the virus replicates.

5 Dec 2012

Data from OncoSec Medical clinical studies to be presented at DNA Vaccines 2012 Conference

OncoSec Medical Inc., a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumor cancers, announced it will be presenting at the DNA Vaccines 2012 Conference at the Loews Coronado Bay Resort in San Diego, California. OncoSec is a Silver Sponsor of the conference.

4 Dec 2012

EC grants CE mark to InSightec’s ExAblate Neuro ultrasound system

InSightec Ltd. announced that its transcranial focused ultrasound system, ExAblate Neuro, has been awarded the European CE mark for the treatment of neurological disorders in the brain including essential tremor, Parkinson's disease and neuropathic pain.

4 Dec 2012

VTT's PredictAD system promises to enable earlier diagnosis of Alzheimer's

A software tool called PredictAD developed by VTT Technical Research Centre of Finland promises to enable earlier diagnosis of the disease on the basis of patient measurements and large databases. Alzheimer's disease currently takes on average 20 months to diagnose in Europe.

4 Dec 2012

InSightec receives European CE mark for ExAblate Neuro system

Elbit Imaging Ltd. announced today that on December 3, 2012, Elbit Medical Technologies Ltd., announced that InSightec Ltd. has been awarded the European CE mark for its transcranial focused ultrasound system, ExAblate Neuro, with respect to the treatment of neurological disorders in the brain, including essential tremor, Parkinson's disease and neuropathic pain.

4 Dec 2012

Sorin Group’s Mitroflow valve receives Japanese PMDA approval

Sorin Group, a global medical company and a leader in the treatment of cardiovascular diseases, announced today that it received the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) approval for the Mitroflow Aortic Pericardial Heart Valve.

4 Dec 2012

Researchers describe role of calcium in ability of Yersinias to cause disease

A more than 50-year-old question has now been answered. Chemists and microbiologists at the Biological Chemistry Center at Umeå University in Sweden are now able to describe in detail the role of calcium in the ability of the plague bacterium Yersinias to cause disease.

4 Dec 2012

Studies explore F-18-FLT PET utility in providing prognostic information for patients with gliomas

In the management of gliomas-or tumors that originate in the brain-precise assessment of tumor grade and the proliferative activity of cells plays a major role in determining the most appropriate treatment and predicting overall survival.

4 Dec 2012

Pipeline embolization device shows promise in treating brain aneurysms

A new technology called the Pipeline embolization device (PED) shows encouraging results in patients with certain types of difficult-to-treat brain aneurysms, reports the December issue of Neurosurgery, official journal of the Congress of Neurological Surgeons.

4 Dec 2012

Study examines effectiveness of German mammography screening program

How effective is the German mammography screening program? This is the question examined by Oliver Heidinger of the Epidemiological Cancer Registry North Rhine-Westphalia and his co-authors in the first study on this subject in Germany, in Deutsches -rzteblatt International.

4 Dec 2012

Bruker secures major orders for its new SP9900+ 3D Optical Microscope

Bruker announced today that it has already received more than $7 million in orders for its new Bruker SP9900+ high-throughput high density interconnect (HDI) substrate metrology system, and has begun shipping the product in volume.

From Bruker Nano Surfaces and Metrology 3 Dec 2012

Hip prosthesis lasts for over 20 years

The Zweymüller prosthesis, developed at the end of the 1970s, was one of the first to be anchored in the bone without using bone cement to fix it in place. The prosthesis's special geometry and surface guarantee its stable anchoring and natural integration into the bone.

3 Dec 2012

AliveCor receives FDA clearance on its mobile heart monitor

AliveCor, Inc. announced today at the start of the 4th annual mHealth Summit in Washington, D.C. that the company received FDA 510(k) clearance on its mobile Heart Monitor as well as CE Mark conformity. This clinical-quality, low-cost mobile ECG heart monitor, compatible with the iPhone® 4 and 4S, enables doctors to evaluate patient heart health easily, quickly and remotely.

3 Dec 2012

Ansell introduces GAMMEX N95 Respirator and Surgical Mask

Ansell, a global leader in protection solutions today announced the latest addition to its Active Infection Protection (AIP) portfolio, the GAMMEX N95 Respirator and Surgical Mask, extending the AIP range beyond surgical gloves.

3 Dec 2012

ADVENTRX Pharmaceuticals updates corporate website

ADVENTRX Pharmaceuticals, Inc. today announced the launch of its redesigned and updated corporate website,www.adventrx.com. The new website features clinician videos, patient resources, and important news pertaining to sickle cell disease and ADVENTRX's lead product candidate, ANX-188 (purified poloxamer 188).

3 Dec 2012